Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of ...
Dot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management ...
An Investigational Device Exemption (IDE) allows an investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval ...
Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions, today announced the submission of its Investigational Device ...
Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, ...
Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA
Kennewick, WA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Following the 30-day review period, the FDA declined approval of the Radiogel® IDE submission. We are now focused on ...
J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like ...
The final guidance issued on Wednesday establishes new recommendations and considerations for a live or pre-recorded broadcast of a surgical or percutaneous procedure under an investigational device ...
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the 10 best robotics and automation stocks to invest in. On May 28, PROCEPT ...
Artivion has received premarket approval application (PMA) clearance from the US Food and Drug Administration (FDA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results